This protocol is judged by an institutional critique board, an unbiased team that critiques any medical trials involving individuals. If a review will involve a Plan I drug, once the board approves the protocol as ethical, the researchers must submit an application for an investigational new drug (IND) range within the FDA.copyright very first bec